These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 18449937

  • 1. Formulation development and process scale up of a high shear wet granulation formulation containing a poorly wettable drug.
    He X, Lunday KA, Li LC, Sacchetti MJ.
    J Pharm Sci; 2008 Dec; 97(12):5274-89. PubMed ID: 18449937
    [Abstract] [Full Text] [Related]

  • 2. Search for technological reasons to develop a capsule or a tablet formulation with respect to wettability and dissolution.
    von Orelli J, Leuenberger H.
    Int J Pharm; 2004 Dec 09; 287(1-2):135-45. PubMed ID: 15541920
    [Abstract] [Full Text] [Related]

  • 3. Development of a rapidly dispersing tablet of a poorly wettable compound: formulation DOE and mechanistic study of effect of formulation excipients on wetting of celecoxib.
    He X, Barone MR, Marsac PJ, Sperry DC.
    Int J Pharm; 2008 Apr 02; 353(1-2):176-86. PubMed ID: 18207339
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
    Patel NV, Chotai NP, Patel MP.
    Pharmazie; 2008 Apr 02; 63(4):275-81. PubMed ID: 18468386
    [Abstract] [Full Text] [Related]

  • 6. The combined effect of wet granulation process parameters and dried granule moisture content on tablet quality attributes.
    Gabbott IP, Al Husban F, Reynolds GK.
    Eur J Pharm Biopharm; 2016 Sep 02; 106():70-8. PubMed ID: 27016211
    [Abstract] [Full Text] [Related]

  • 7. Twin screw granulation as a simple and efficient tool for continuous wet granulation.
    Keleb EI, Vermeire A, Vervaet C, Remon JP.
    Int J Pharm; 2004 Apr 01; 273(1-2):183-94. PubMed ID: 15010142
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Understanding and optimizing the dual excipient functionality of sodium lauryl sulfate in tablet formulation of poorly water soluble drug: wetting and lubrication.
    Aljaberi A, Chatterji A, Dong Z, Shah NH, Malick W, Singhal D, Sandhu HK.
    Pharm Dev Technol; 2013 Apr 01; 18(2):490-503. PubMed ID: 23009028
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of process parameters and equipment on dry foam formulation properties using indomethacin as model drug.
    Sprunk A, Page S, Kleinebudde P.
    Int J Pharm; 2013 Oct 15; 455(1-2):189-96. PubMed ID: 23891743
    [Abstract] [Full Text] [Related]

  • 12. Dissolution and disintegration kinetics of high-active pharmaceutical granules produced at laboratory and manufacturing scale.
    Smrčka D, Dohnal J, Štěpánek F.
    Eur J Pharm Biopharm; 2016 Sep 15; 106():107-16. PubMed ID: 27063417
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative study of telmisartan tablets prepared via the wet granulation method and pritor™ prepared using the spray-drying method.
    Park J, Park HJ, Cho W, Cha KH, Yeon W, Kim MS, Kim JS, Hwang SJ.
    Arch Pharm Res; 2011 Mar 15; 34(3):463-8. PubMed ID: 21547679
    [Abstract] [Full Text] [Related]

  • 15. Use of a continuous twin screw granulation and drying system during formulation development and process optimization.
    Vercruysse J, Peeters E, Fonteyne M, Cappuyns P, Delaet U, Van Assche I, De Beer T, Remon JP, Vervaet C.
    Eur J Pharm Biopharm; 2015 Jan 15; 89():239-47. PubMed ID: 25528462
    [Abstract] [Full Text] [Related]

  • 16. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.
    Salazar J, Müller RH, Möschwitzer JP.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):565-77. PubMed ID: 23587645
    [Abstract] [Full Text] [Related]

  • 17. Application of near-infrared spectroscopy to optimize dissolution profiles of tablets according to the granulation mechanism.
    Shikata F, Kimura S, Hattori Y, Otsuka M.
    Drug Dev Ind Pharm; 2018 May 16; 44(5):713-722. PubMed ID: 29192801
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The preparation of orally disintegrating tablets using a hydrophilic waxy binder.
    Abdelbary G, Prinderre P, Eouani C, Joachim J, Reynier JP, Piccerelle P.
    Int J Pharm; 2004 Jul 08; 278(2):423-33. PubMed ID: 15196646
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.